Mill Creek Capital Advisors’s Pfizer PFE Stock Holding History

Mill Creek Capital Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-7,348	Closed	-$206K	–	265
2024 Q2	$206K	Sell	7,348 -423	-5%	-$11.6K	0.01%	246
2024 Q1	$216K	Sell	7,771 -1,387	-15%	-$38.5K	0.01%	222
2023 Q4	$264K	Buy	9,158 +1,519	+20%	+$45.9K	0.01%	203
2023 Q3	$253K	Sell	7,639 -4,709	-38%	-$167K	0.01%	191
2023 Q2	$453K	Sell	12,348 -22,133	-64%	-$861K	0.01%	155
2023 Q1	$1.41M	Sell	34,481 -1,199	-3%	-$51.8K	0.05%	83
2022 Q4	$1.83M	Buy	+35,680	New	+$1.71M	0.08%	71

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Mill Creek Capital Advisors's PFE Position: Q3 2024 in Review

Mill Creek Capital Advisors sold out of Pfizer (PFE) in Q3 2024, closing a stake of 7,348 shares — an estimated $206K sold.

Mill Creek Capital Advisors first reported a position in PFE in Q4 2022 and held it in 7 quarters. The position peaked at $1.83M in Q4 2022. 2,910 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

Mill Creek Capital Advisors reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
Mill Creek Capital Advisors sold 7,348 Pfizer shares in Q3 2024, an estimated $206K.
Mill Creek Capital Advisors first reported a position in Pfizer in Q4 2022 and held it in 7 quarters.
Mill Creek Capital Advisors's Pfizer position peaked at $1.83M in Q4 2022.
2,910 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Mill Creek Capital Advisors's 13F filing for Q3 2024, filed 6 Nov 2024.